Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks
Funds research on whether HIV immunotherapies reach and calm the brain's viral reservoir without causing neurological harm.
Treating HIV in the blood does not necessarily treat it in the brain. This notice funds finding out what immunotherapies do once they cross that line.
The work is biphasic, evaluating the impact of HIV immunotherapies on central nervous system (CNS) outcomes in people with HIV, and identifying the mechanisms, benefits and risks of using them in the CNS compartment specifically.
The primary goal …
Biphasic research evaluating the impact of HIV immunotherapies on central nervous system outcomes in people with HIV, identifying mechanisms, benefits and risks in the CNS compartment — including blood-brain barrier penetration, compartmentalised viral dynamics and immune-mediated effects — toward sustained virologic remission and improved neurologic and cognitive outcomes.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up